Bisphosphonates for metastatic bone pain

被引:0
|
作者
J. J. Body
机构
[1] Supportive Care Clinic & Bone Diseases Clinic,
[2] Institut J. Bordet,undefined
[3] Univ. Libre de Bruxelles,undefined
[4] 1,undefined
[5] rue Héger-Bordet,undefined
[6] B-1000 Brussels,undefined
[7] Belgium,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1 / 3
页数:2
相关论文
共 50 条
  • [31] Should bisphosphonates be the treatment of choice for metastatic bone disease?
    Coleman, RE
    SEMINARS IN ONCOLOGY, 2001, 28 (04) : 35 - 41
  • [32] Bisphosphonates and radiation therapy for palliation of metastatic bone disease
    Hoskin, PJ
    CANCER TREATMENT REVIEWS, 2003, 29 (04) : 321 - 327
  • [33] In vitro and in vivo antiresorptive effects of bisphosphonates in metastatic bone disease
    Kanakis, I
    Kousidou, OC
    Karamanos, NK
    IN VIVO, 2005, 19 (01): : 311 - 318
  • [34] Interaction between bisphosphonates and taxanes in patients with metastatic bone disease
    Luis, I.
    Alho, I.
    Ribeiro, J.
    Fernandes, I.
    Semedo, M.
    Rodrigues, T.
    Vicente, O.
    Casimiro, S.
    Costa, L.
    EJC SUPPLEMENTS, 2009, 7 (02): : 285 - 285
  • [35] The use of bisphosphonates in the management of bone metastatic prostate cancer.
    Mercadante S.
    Current Urology Reports, 2002, 3 (3) : 244 - 249
  • [36] Ibandronate in metastatic bone pain
    Heidenreich, A
    Ohlmann, C
    Body, JJ
    SEMINARS IN ONCOLOGY, 2004, 31 (05) : 67 - 72
  • [37] Opioids for metastatic bone pain
    Hara, Satoshi
    ONCOLOGY, 2008, 74 : 52 - 54
  • [38] Management of metastatic bone pain
    Payne, R
    Janjan, N
    ASSESSMENT AND TREATMENT OF CANCER PAIN, 1998, 12 : 269 - 273
  • [39] Radioisotopes for metastatic bone pain
    Hoskin, PJ
    LANCET ONCOLOGY, 2005, 6 (06): : 353 - 354
  • [40] Managing metastatic bone pain
    Dewar, JA
    BRITISH MEDICAL JOURNAL, 2004, 329 (7470): : 812 - 813